Mission Bio

Today, we're thrilled to announce the Tapestri Single-cell Multiple Myeloma Multiomics Solution! 🎉 This groundbreaking product suite is set to transform MM research and therapeutic development, offering unparalleled insights into disease evolution and biology at the single-cell level. 🔬 Our new solution integrates genomic, proteomic, and clonotypic assessments in a single assay, providing comprehensive clonal and subclonal insights that surpass existing bulk methodologies. This will empower researchers and drug developers to fully dissect the molecular and cellular landscape of myeloid progression, understand therapy resistance, and address disease relapse more effectively. Stay tuned for more details, including late-breaking data to be presented at the European Hematology Association (EHA) Congress on June 14. 📅 Check out our press release to learn more https://bit.ly/4e9AEtE #multiplemyeloma #singlecell #multiomics #pressrelease #eha2024

🎬 On-Demand Presentation 🎬 Presented at this year's World CB & CDx US conference, learn how single-cell multiparametric data sets can be leveraged to advance heme oncology pipelines. In this presentation, we cover: 🔬 How Multiple Myeloma and its associated resistance mechanisms leave researchers with unresolved questions - and how these questions impact therapeutic treatments over time 🔬 How insights gained from single-cell multiomics may be leveraged to address these lingering unresolved questions 🔬 Review a real-world case study that highlights our Tapestri Single-cell Myeloma Multiomics Solution, and how our assays may be used to study other myeloid malignancies Watch on-demand anytime here ⬇ https://lnkd.in/gh-62Afm

That's a wrap on Biomarkers US 2024! 👏 A special thank you to everyone who packed the room to hear from our expert Holly Baden-Tillson today as she discussed how to leverage single-cell analysis to better understand multiple myeloma and myeloid malignancies. Learn more here 👉 https://lnkd.in/gNc_pZWw

We had a great time today at the first day of the 8th Annual Biomarker & Precision Medicine US Congress 🔬 If you're attending, Andrew Rohs and Holly Baden-Tillson are on deck to answer all your questions about how single-cell analysis enables biomarker discovery & characterization! https://lnkd.in/g5vQe49w

Ciao Roma! 👋 🇮🇹 We had a fantastic time at #ESGCT24 this year, with a special thank you to everyone who stopped by our posters and booth! If you didn't get a chance to view our posters, fear not! You can check them out anytime on our website 👇 🗒 Single-cell Multi-omics Analysis Reveals Differential Lineage-specific Vector Copy Number Distribution in CAR-T Cell Products: https://lnkd.in/gECKYxbc 🗒 High Throughput Single-cell Assessment of Genome Integrity and Toxicity Events Associated With Edited Cells: https://lnkd.in/g6x4w28p

#ESGCT24 is in full swing! If you're attending, be sure to catch all the exciting posters that showcase single-cell analysis for cell and gene therapies: P0574: Monitoring repair outcomes of CRISPR genome-editing at the single-cell level. Ayal Hendel, Bar-Ilan University P0528: Single-cell assessment of genome integrity and toxicity events associated with edited cell therapies  P0758: Single-cell multi-omics analysis reveals differential lineage-specific vector copy number distribution in CAR-T cell product Not attending ESGCT? You can check out our posters here: https://lnkd.in/gA3XWGYU

Our crew is in Rome and kicking off the first day of #ESGCT24! 🇮🇹 Stop by the Mission Bio booth to say hello and learn more about how to comprehensively analyze genome-wide CNVs across thousands of cells with our Genome Integrity Solution.

It is with deep sadness that we share the news of the passing of our beloved friend, leader, and colleague, George Kopitas, who left us last week. For over six years at Mission Bio as a commercial leader, George was dedicated to empowering our customers through single-cell genomics, helping them unlock the potential of precision medicine. But George’s impact went beyond building our commercial team—he created a true community, a family of colleagues united by a shared mission. As a leader, George led by example, embodying kindness, humility, and grace in everything he did. He taught us that true leadership is not defined by power, but by the lasting legacy of empowerment you leave behind. Many of us who had the privilege of working alongside George will never forget his infectious laughter and sense of humor, which lifted us all during the toughest times. We invite you to share your memories of George as we celebrate his life. If you are in a position to support his family during this difficult time, we encourage you to donate. Our deepest condolences go out to his family, friends, and the countless people whose lives he touched. He will be profoundly missed. You can visit George's memorial website here: https://lnkd.in/gN_p75Pt

Be sure to visit Georg Papoutsoglou and Gema Fuerte Hortigón at DGHO!

We're thrilled to announce the Tapestri Genome Integrity CNV Solution is now available! This powerful solution unlocks numerous applications in therapeutic development and oncology research: 🚀  Combine Gene Editing & Genome Integrity Analysis: Enhance CRISPR-edited cell safety profiling with a multi-attribute approach. 🚀  Assess Stem Cells Post-Reprogramming or Differentiation: Detect genomic aberrations with improved throughput. 🚀  Evaluate Clonal and Subclonal Heterogeneity: Gain insights into CNV linked to tumor evolution and therapeutic resistance immune evasion. 🚀  Correlate Multiomic Data: Combine CNV, SNV, and surface immunophenotypic measurements at single-cell resolution. Learn more about how you can empower your research here 👉 https://lnkd.in/gzy4whn7